Total Payments
$1,352
2024 Payments
$214.69
Companies
16
Transactions
88
Medicare Patients
2,977
Medicare Billing
$167,657
Payment Breakdown by Category
Food & Beverage$1,337 (98.9%)
Education$15.03 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,337 | 87 | 98.9% |
| Education | $15.03 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $523.98 | 35 | $0 (2024) |
| PFIZER INC. | $138.40 | 10 | $0 (2020) |
| Lilly USA, LLC | $103.16 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $98.03 | 7 | $0 (2019) |
| ABBVIE INC. | $91.86 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $80.19 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $76.49 | 6 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $54.31 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.40 | 3 | $0 (2019) |
| Amgen Inc. | $40.48 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $214.69 | 2 | Novo Nordisk Inc ($122.83) |
| 2020 | $78.12 | 6 | Novo Nordisk Inc ($27.41) |
| 2019 | $212.41 | 15 | PFIZER INC. ($60.23) |
| 2018 | $538.11 | 36 | Novo Nordisk Inc ($221.35) |
| 2017 | $309.08 | 29 | Novo Nordisk Inc ($112.04) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Obesity | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $91.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 06/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/11/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/07/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/26/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/01/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/24/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: GASTROINTESTINAL | ||||||
| 09/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Diabetes | ||||||
| 07/17/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Diabetes | ||||||
| 07/16/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes | ||||||
| 06/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: DIABETES | ||||||
| 06/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes | ||||||
| 05/07/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2019 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/12/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Diabetes | ||||||
| 10/09/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 315 | 445 | $72,521 | $21,175 |
| 2022 | 9 | 327 | 467 | $68,480 | $20,665 |
| 2021 | 10 | 288 | 360 | $63,222 | $19,458 |
| 2020 | 31 | 2,047 | 3,959 | $345,817 | $106,359 |
Total Patients
2,977
Total Services
5,231
Medicare Billing
$167,657
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 126 | $36,666 | $9,553 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 85 | $17,085 | $4,210 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $8,034 | $3,175 | 39.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $1,469 | $1,151 | 78.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 127 | $1,397 | $1,067 | 76.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,704 | $1,029 | 21.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $882.00 | $525.06 | 59.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 12 | $2,100 | $415.44 | 19.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 23 | $184.00 | $48.40 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 105 | $30,555 | $8,464 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 113 | $22,713 | $6,995 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $8,961 | $3,642 | 40.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 20 | 20 | $3,500 | $694.91 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $588.00 | $336.48 | 57.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 62 | 95 | $1,045 | $281.61 | 26.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 18 | $882.00 | $196.64 | 22.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 23 | $184.00 | $51.20 | 27.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 13 | 52 | $52.00 | $4.73 | 9.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 117 | $33,027 | $10,125 | 30.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 63 | $12,663 | $4,074 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $4,902 | $2,080 | 42.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $5,445 | $1,785 | 32.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $4,032 | $621.39 | 15.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 60 | 79 | $869.00 | $237.00 | 27.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 19 | $945.00 | $189.32 | 20.0% |
About Dr. Shawn Lazoff, DO
Dr. Shawn Lazoff, DO is a Family Medicine healthcare provider based in Summerfield, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982993309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shawn Lazoff, DO has received a total of $1,352 in payments from pharmaceutical and medical device companies, with $214.69 received in 2024. These payments were reported across 88 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,337).
As a Medicare-enrolled provider, Lazoff has provided services to 2,977 Medicare beneficiaries, totaling 5,231 services with total Medicare billing of $167,657. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Summerfield, NC
- Active Since 04/06/2011
- Last Updated 04/30/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982993309
Products in Payments
- Victoza (Drug) $143.14
- Tresiba (Drug) $132.02
- Wegovy (Drug) $122.83
- JARDIANCE (Drug) $104.15
- QULIPTA (Drug) $91.86
- CHANTIX (Drug) $60.46
- Ozempic (Drug) $56.87
- XARELTO (Drug) $44.48
- BEVESPI AEROSPHERE (Drug) $39.87
- TOUJEO (Drug) $39.77
- TRELEGY ELLIPTA (Drug) $36.56
- INVOKANA (Drug) $35.71
- Vascepa (Drug) $31.22
- LYRICA (Drug) $29.80
- Aimovig (Biological) $29.04
- Xultophy 100/3.6 (Drug) $26.89
- FARXIGA (Drug) $26.44
- NUEDEXTA (Drug) $18.16
- BYDUREON (Drug) $17.26
- SHINGRIX (Biological) $16.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Summerfield
Martha Alvarez, Fnp-Bc, FNP-BC
Family Medicine — Payments: $1,140
Family Medicine $1,140
Jerome Carolino, Md, MD
Family Medicine — Payments: $699.88
Family Medicine $699.88
Dr. Fred Wilson, Md, MD
Family Medicine — Payments: $691.25
Family Medicine $691.25
Timothy Lockamy, Do, DO
Family Medicine — Payments: $330.16
Family Medicine $330.16
Kristen Kaplan, Pa-C, PA-C
Family Medicine — Payments: $36.56
Family Medicine $36.56
Dr. Kellyann Curnayn, Dnp, Aprn-Bc, DNP, APRN-BC
Family Medicine — Payments: $27.87
Family Medicine $27.87